$19.33
-0.07-0.36%
Last update: 8:52 AM
15 minutes delayed
Fresenius Medical Care
FMSNYSE
Fresenius Medical Care (NYSE:FMS) Stock, Analyst Ratings, Price Targets, Forecasts
Fresenius Medical Care AG has a consensus price target of $16.2 based on the ratings of 11 analysis. The 3 most-recent analyst ratings were released by Truist Securities, Truist Securities, and Truist Securities on May 15, 2024, October 11, 2023, and July 13, 2023, respectively. With an average price target of $25.33 between Truist Securities, Truist Securities, and Truist Securities, there's an implied 32.08% upside for Fresenius Medical Care AG from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
HSBC
Truist Securities
RBC Capital
Jefferies
1calculated from analyst ratings
Analyst Ratings for Fresenius Medical Care
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 25.13% | Truist Securities | David Macdonald | $21 → $24 | Maintains | Hold | Get Alert |
| 11/24/2023 | Buy Now | — | HSBC | Sezgi Oezener | — | Upgrade | Reduce → Hold | Get Alert |
| 10/11/2023 | Buy Now | 25.13% | Truist Securities | David Macdonald | $28 → $24 | Maintains | Hold | Get Alert |
| 07/13/2023 | Buy Now | 45.99% | Truist Securities | David Macdonald | $26 → $28 | Maintains | Hold | Get Alert |
| 05/10/2023 | Buy Now | 35.56% | Truist Securities | David Macdonald | $24 → $26 | Maintains | Hold | Get Alert |
| 04/13/2023 | Buy Now | 25.13% | Truist Securities | David Macdonald | $22 → $24 | Maintains | Hold | Get Alert |
| 02/23/2023 | Buy Now | 14.7% | Truist Securities | — | $17 → $22 | Maintains | Hold | Get Alert |
| 06/22/2022 | Buy Now | 40.77% | Truist Securities | David Macdonald | $34 → $27 | Maintains | Hold | Get Alert |
| 11/23/2021 | Buy Now | — | HSBC | Sezgi Oezener | — | Initiates | → Hold | Get Alert |
| 11/17/2021 | Buy Now | 82.48% | RBC Capital | Frank Morgan | — | Maintains | Sector Perform | Get Alert |
| 11/11/2021 | Buy Now | — | Jefferies | James VaneTempest | — | Upgrade | Underperform → Hold | Get Alert |
FAQ
What is the target price for Fresenius Medical Care (FMS) stock?
The latest price target for Fresenius Medical Care (NYSE:FMS) was reported by Truist Securities on May 15, 2024. The analyst firm set a price target for $24.00 expecting FMS to rise to within 12 months (a possible 24.16% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fresenius Medical Care (FMS)?
The latest analyst rating for Fresenius Medical Care (NYSE:FMS) was provided by Truist Securities, and Fresenius Medical Care maintained their hold rating.
When was the last upgrade for Fresenius Medical Care (FMS)?
The last upgrade for Fresenius Medical Care AG happened on November 24, 2023 when HSBC raised their price target to N/A. HSBC previously had a reduce for Fresenius Medical Care AG.
When was the last downgrade for Fresenius Medical Care (FMS)?
There is no last downgrade for Fresenius Medical Care.
When is the next analyst rating going to be posted or updated for Fresenius Medical Care (FMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fresenius Medical Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fresenius Medical Care was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Fresenius Medical Care (FMS) correct?
While ratings are subjective and will change, the latest Fresenius Medical Care (FMS) rating was a maintained with a price target of $21.00 to $24.00. The current price Fresenius Medical Care (FMS) is trading at is $19.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.